PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.

Main|Search|PHGKB






Last Posted: Jul 26, 2018

---

• PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
  Sawa Kenji et al. Lung cancer (Amsterdam, Netherlands) 2017 Oct 11296-101
• Precision medicine in COPD exacerbations.
  Agusti Alvar et al. The Lancet. Respiratory medicine 2018 Jul
• Advances in managing COPD related to α 1 -antitrypsin deficiency, an under-recognized genetic disorder.
  Craig Timothy J et al. Allergy 2018 Jul
• Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
  Greulich Timm et al. COPD 2017 Mar 14(sup1) S8-S11
• Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
  Rahaghi Franck F et al. Respiratory research 2017 May 18(1) 105
• Clinical and molecular markers in COPD.
  Gonçalves I et al. Pulmonology 2018 Jun
• Personalized medicine for chronic, complex diseases: chronic obstructive pulmonary disease as an example.
  Radder Josiah E et al. Personalized medicine 2014 Sep 11(7) 669-679
• Living With COPD 
• New Ads From Former Smokers
  CDC Tips Campaign, 2018
• Prioritizing complex disease risk genes by integrating multiple data.
  Guo Shanshan et al. Genomics 2018 Apr

more